Thrive Wealth Management LLC Reduces Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Thrive Wealth Management LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 6.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,798 shares of the healthcare conglomerate’s stock after selling 126 shares during the quarter. Thrive Wealth Management LLC’s holdings in UnitedHealth Group were worth $910,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the company. Pacer Advisors Inc. grew its stake in UnitedHealth Group by 5.7% in the second quarter. Pacer Advisors Inc. now owns 65,860 shares of the healthcare conglomerate’s stock worth $33,540,000 after purchasing an additional 3,525 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC increased its holdings in UnitedHealth Group by 3.4% during the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 700,864 shares of the healthcare conglomerate’s stock valued at $356,922,000 after buying an additional 23,129 shares during the period. ProShare Advisors LLC increased its holdings in shares of UnitedHealth Group by 7.9% in the 2nd quarter. ProShare Advisors LLC now owns 245,171 shares of the healthcare conglomerate’s stock valued at $124,856,000 after acquiring an additional 17,861 shares during the period. Frank Rimerman Advisors LLC grew its position in shares of UnitedHealth Group by 61,354.2% in the 2nd quarter. Frank Rimerman Advisors LLC now owns 14,749 shares of the healthcare conglomerate’s stock worth $7,511,000 after buying an additional 14,725 shares during the last quarter. Finally, 1832 Asset Management L.P. grew its holdings in UnitedHealth Group by 12.0% in the second quarter. 1832 Asset Management L.P. now owns 1,797,607 shares of the healthcare conglomerate’s stock worth $915,449,000 after purchasing an additional 192,128 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Royal Bank of Canada dropped their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. UBS Group cut their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday. Piper Sandler decreased their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Finally, Truist Financial decreased their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Two analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $627.74.

UnitedHealth Group Stock Down 0.1 %

Shares of NYSE:UNH opened at $510.03 on Monday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $469.37 billion, a price-to-earnings ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62. The business has a 50-day moving average price of $549.37 and a 200 day moving average price of $563.18. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the business posted $5.83 earnings per share. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.